The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...

Experts with the Cleveland Clinic say the drug has a lot of potential, especially since it is considered nonaddictive.

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

Virtual reality has been a standout technology in the medical industry since the turn of the decade. From its use as a ...

( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...

The ad films discuss issues like lengthy processes, lack of transparency, anxiety and mental stress involved with traditional ...

Autoimmune disorders in children can cause symptoms often mistaken for common childhood illnesses. More precise diagnoses and ...

Migraines affect millions worldwide, yet remain widely misunderstood. This neurological condition extends far beyond typical headache symptoms, often ...

LAS VEGAS - ALT5 Sigma Corporation (NASDAQ:ALTS), a fintech company specializing in blockchain technologies with a market capitalization of $92.86 million, has announced a partnership with Odoo, a ...

An inquest into the homicide of a grandfather who died at the hands of a dementia patient in an aged care facility has found ...

Operators in the construction sector have called for the adoption of wearable robots for construction workers to avert ...